Back
Voyager Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
19
VYGR
Voyager Therapeutics
Last Price:
$2.74
Seasonality Move:
-9.65%
Sell
36
NBY
NovaBay Pharmaceuticals
Last Price:
$0.57
Seasonality Move:
-4.65%
Sell
19
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
-
The current Voyager Therapeutics [VYGR] share price is $2.74. The Score for VYGR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
VYGR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
36
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.55. The Score for NBY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $2.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.55The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 33.87 | Sell |
Chaikin Money Flow: | -48266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.98 - 3.52) | Sell |
Bollinger Bands (100): | (3.13 - 5.03) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 40.62 | Sell |
Chaikin Money Flow: | -7035 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.57 - 0.59) | Sell |
Bollinger Bands (100): | (0.56 - 0.68) | Sell |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.95 | Sell |
20-day SMA: | 3.18 | Sell |
50-day SMA: | 3.31 | Sell |
200-day SMA: | 5.25 | Sell |
8-day EMA: | 2.92 | Sell |
20-day EMA: | 3.11 | Sell |
50-day EMA: | 3.43 | Sell |
200-day EMA: | 5.04 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.56 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.57 | Sell |
200-day SMA: | 0.61 | Sell |
8-day EMA: | 0.56 | Sell |
20-day EMA: | 0.57 | Sell |
50-day EMA: | 0.58 | Sell |
200-day EMA: | 2.02 | Sell |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.02 per share, a decrease this year of $1.18 per share, and an increase next year of $0.47 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Voyager Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |